A Single-centre, Randomised, Double-blind, Placebo Controlled, Two 12 Week Period, Cross-over Phase III Study to Investigate the Effect of Rosiglitazone 4mg bd on the Vasodilator Response to Hyperinsulinaemia in Obese Insulin Resistant Subjects.
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00000230/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Fluid management study in patients with insulin resistance.
胰岛素抵抗（insulin resistance）患者液体管理研究
提供机构：
Vivli
创建时间：
2018-10-27
